Completed PHASE2 INTERVENTIONAL 2-arm NCT02425436

Role of Ginkgo Biloba Extract in IUGR

Effects of Oral Ginkgo Biloba Extract on Pregnancy Complicated by Asymmetrically Intrauterine Growth Restriction: a Double-blinded Randomized Placebo-controlled Trial

Sponsor: Assiut University

Conditions Intrauterine Growth Restriction (IUGR)

Interventions Ginkgo Biloba Extract Placebo

Updated 5 times since 2017 Last updated: Mar 20, 2016 Started: May 31, 2014 Primary completion: Oct 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02425436, this PHASE2 trial focuses on Intrauterine Growth Restriction (IUGR) and remains completed. Sponsored by Assiut University, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.